Skip to main content
Mankind Pharma Limited logo

Mankind Pharma Limited — Investor Relations & Filings

Ticker · MANKIND ISIN · INE634S01028 LEI · 33580067G8AZ7S8NYA02 BSE.NS Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS MANKIND

About Mankind Pharma Limited

https://www.mankindpharma.com/

Mankind Pharma Limited focuses on the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations and consumer healthcare products. The company’s portfolio spans various therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, dermatology, and respiratory health. It maintains a significant presence in the over-the-counter segment with brands such as Manforce, Prega News, and Gas-O-Fast. The organization operates a robust research and development infrastructure dedicated to creating affordable and accessible medicinal solutions. Its operational model leverages an extensive distribution network to ensure product availability across diverse geographic regions, prioritizing high-quality healthcare delivery and patient-centric innovation.

Recent filings

Filing Released Lang Actions
Please find attached intimation regarding participation in investor conference
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure letter to stock exchanges (BSE/NSE) under SEBI Listing Regulations, informing about management’s participation in investor conferences. It does not present financial data, earnings results, or constitute a report but is a compliance announcement. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, providing an intimation to stock exchanges of the company’s participation in investor conferences. It does not contain financial data, results, or constitute a report itself, nor does it fit any specific category like earnings releases or management presentations. It is a generic compliance announcement, so it falls under Regulatory Filings (RNS).
2026-05-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 98% confidence The document is a full transcript of Mankind Pharma’s Q4 & FY26 investor conference call, including management presentations and Q&A. It is clearly a conference call transcript, so it falls under the Call Transcript category.
2026-05-26 English
Please find attached transcript of the Investor Conference Call held on May 20, 2026
Call Transcript Classification · 85% confidence The document is the full text transcript of Mankind Pharma’s Q4 & FY26 investor conference call, including introductions, management remarks, financial performance commentary, and Q&A structure. It is clearly a call transcript under Regulation 30 disclosures, not just an earnings release or investor presentation. Therefore, it matches the definition of a Call Transcript (CT).
2026-05-26 English
Intimation of participation in the Investors Meeting
Regulatory Filings Classification · 78% confidence The document is a stock exchange filing under SEBI Listing Regulations (Regulation 30) notifying participation in investor meetings. It does not contain financial results, detailed presentations, or substantive data, nor does it propose a transaction or board change. It is a routine regulatory disclosure, so it falls under the general “Regulatory Filings” category.
2026-05-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an intimation under SEBI Listing Obligations (Regulation 30) to stock exchanges about management’s upcoming investor meetings. It contains no financial statements or substantive data, nor is it announcing a report or dividend. It is a general regulatory disclosure, fitting the fallback category for miscellaneous filings. Thus, it should be classified as a Regulatory Filing (RNS).
2026-05-20 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.